WASHINGTON, Jan 16 (Reuters) - The U.S. Supreme Court agreed ‌on ​Friday to hear a patent dispute ‌involving Amarin Pharma's ...
On January 16, 2026, the U.S. Supreme Court agreed to hear Hikma Pharmaceuticals USA, Inc. v. Amarin Pharma, Inc., a patent ...
On Friday, the U.S. Supreme Court granted certiorari to a petition filed by patent owner Hikma Pharmaceuticals, taking up ...
The U.S. Supreme Court has decided to hear a case between Amarin Pharma and generic drugmaker Hikma that puts so-called ...
As thousands of protestors demonstrate in Washington, DC, at Friday’s annual March for Life, the Trump administration faces a deadline to explain why it opposes a lawsuit that could end the ...
Sidelined last election, abortion returns to policy limelight - Health Care Abortion returns to policy discussions after ...
The White House and Congress seem uninterested in new pro-life measures. But crisis pregnancy centers will continue their mission, one life at a time.
Shares of Bayer AG BAYRY gained 6.41% on Jan. 19, after the company announced that the Supreme Court agreed to review the ...
The Senate’s health committee convened its first hearing of the year on the efficacy of the chemical abortion drug ...
It has long been ignored that the Biden administration de facto guaranteed legal abortion in all 50 states just 15 days after ...
The fate of a Texas law that makes it a crime to enter the country without authorization could hinge on who has the right to ...
The high court will take up a case from Missouri, in which a jury awarded $1.25 million to a man who developed non-Hodgkin’s ...